title: Mechanisms of cell entry by human papillomaviruses: an overview.
abstract: As the primary etiological agents of cervical cancer, human papillomaviruses (HPVs) must deliver their genetic material into the nucleus of the target cell. The viral capsid has evolved to fulfil various roles that are critical to establish viral infection. The particle interacts with the cell surface via interaction of the major capsid protein, L1, with heparan sulfate proteoglycans. Moreover, accumulating evidence suggests the involvement of a secondary receptor and a possible role for the minor capsid protein, L2, in cell surface interactions.The entry of HPV in vitro is initiated by binding to a cell surface receptor in contrast to the in vivo situation where the basement membrane has recently been identified as the primary site of virus binding. Binding of HPV triggers conformational changes, which affect both capsid proteins L1 and L2, and such changes are a prerequisite for interaction with the elusive uptake receptor. Most HPV types that have been examined, appear to enter the cell via a clathrin-dependent endocytic mechanism, although many data are inconclusive and inconsistent. Furthermore, the productive entry of HPV is a process that occurs slowly and asynchronously and it is characterised by an unusually extended residence on the cell surface.Despite the significant advances and the emergence of a general picture of the infectious HPV entry pathway, many details remain to be clarified. The impressive technological progress in HPV virion analysis achieved over the past decade, in addition to the improvements in general methodologies for studying viral infections, provide reasons to be optimistic about further advancement of this field.This mini review is intended to provide a concise overview of the literature in HPV virion/host cell interactions and the consequences for endocytosis.
authors.affiliation: Applied Molecular Biology Research group, Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.
authors.forename: Caroline A J
authors.initials: CA
authors.lastname: Horvath
authors.forename: Gaëlle A V
authors.initials: GA
authors.lastname: Boulet
authors.forename: Virginie M
authors.initials: VM
authors.lastname: Renoux
authors.forename: Philippe O
authors.initials: PO
authors.lastname: Delvenne
authors.forename: John-Paul J
authors.initials: JP
authors.lastname: Bogers
mesh_terms: D036022:Capsid Proteins / Q000502:physiology; D004705:Endocytosis; D004847:Epithelial Cells / Q000821:virology*; D019812:Heparan Sulfate Proteoglycans / Q000502:physiology; D054884:Host-Pathogen Interactions; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000502:physiology; D027383:Papillomaviridae / Q000502:physiology*; D053585:Virus Attachment; D053586:Virus Internalization
chemical_list: D036022:Capsid Proteins; C114580:HPV L1 protein, Human papillomavirus; D019812:Heparan Sulfate Proteoglycans; D009856:Oncogene Proteins, Viral